Basel, October 29, 2024 – Novartis announced today that Scemblix ® (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with newly diagnosed ...
Developed by Ascentage Pharma, olverembatinib is the first China -approved third-generation BCR:ABL1 inhibitor, currently being jointly commercialized in China by Ascentage Pharma and Innovent ...
Their work can help to lower the ... The Evolution of Green Energy Technology: Developing Three-Dimensional Smart Energy Devices With Radiant Cooling and Solar Absorption Oct. 25, 2024 — - DGIST ...
Based on RNA technology, ICON’s new assay offers huge improvements on how CML is monitored ... NGS assay known as Dup-Seq BCR::ABL1. This innovative assay enables the identification of both ...
Nov. 5, 2024 — Researchers have developed an AI-powered system that mimics the human sense of smell to detect and track toxic gases in real time. Using advanced artificial neural networks ...
The McGraw Center is at the heart of efforts to integrate innovative educational technologies into the academic experience. The center encourages the exploration of new media and digital tools in and ...
The company intends to list the token on a number of other exchanges. This innovative tokenization initiative aims to revolutionize the mining sector by providing a new financing model for mining ...
Join the CML Book Club! The CTV Morning Live hosts will share a new title each month. Read along, share your thoughts, and recommend your favourite books. The CML Book Club’s first selection is ...